
Maharashtra FDA cancels Cipla warehouse's drug sale licences in Pune
The story in brief
Maharashtra FDA revoked Cipla Pharma's wholesale drug sale licences at its Pune warehouse after an inspection found misbranding and storage issues. The cancellation affects regional medicine supply and may disrupt drug availability. Cipla submitted a response and was granted a hearing.